Effects of prenatal exposure to cannabinoids

Area of Science:

• Toxicology
• Developmental Biology
• Pharmacology

Background:

• Prenatal exposure to cannabinoids is a growing public health concern.
• Understanding the developmental effects of cannabinoids is crucial for risk assessment.

Purpose of the Study:

• To review the evidence on the teratogenicity and developmental toxicity of prenatal cannabinoid exposure.
• To identify reliable effects and confounding factors in animal studies.

Main Methods:

• Systematic review of animal studies on prenatal cannabinoid exposure.
• Analysis of dose-response, route of administration, and maternal effects.
• Evaluation of studies with and without controls for maternal undernutrition.

Main Results:

• No consistent gross malformations in humans; limited evidence in mice at high doses/specific routes.
• Increased resorption rates in mice, but not rats.
• Cannabinoid administration reliably decreases maternal food/water intake and weight gain, potentially explaining some offspring effects.
• Decreased birth weight in animals is a consistent finding.
• Long-term postnatal effects are inconsistent and often not observed when maternal factors are controlled.

Conclusions:

• Prenatal cannabinoid exposure does not appear to cause major birth defects in humans.
• Maternal effects, particularly reduced nutrition, are significant confounders in animal studies.
• Controlled studies suggest limited reliable long-term postnatal effects of prenatal cannabinoid exposure.